Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1999
10/06/1999EP0946183A1 Methods of treating or preventing cardiac arrhythmia
10/06/1999EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/06/1999EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/06/1999EP0946172A1 Method for inhibiting stress-activated protein kinases
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999EP0946167A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/06/1999EP0946165A1 Integrin antagonists
10/06/1999EP0946164A1 Integrin antagonists
10/06/1999EP0722326A4 Highly sulfated maltooligosaccharides with heparin-like properties
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230413A Medicine for preventing hypertension cerebral hemorrhage
10/05/1999US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999US5962698 Plasminogen activator inhibitor
10/05/1999US5962682 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962636 Peptides capable of modulating inflammatory heart disease
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962497 A 3,4-diphenyl substituted chroman compound
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962492 Antiasthma agents; antiinflammatory agents
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999US5962472 Alzheimer's, parkinson, huntington diseases; amyotropic laterial sclerosis; nervous system disorders
10/05/1999US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
10/05/1999US5962458 Angiogenesis inhibitors, anticancer agents, antidiabetic agents, skin disorders, autoimmune diseases, antiinflammatory agents, vision defects
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999US5962455 Eating disorders, cardiovascular disorders, hypotensive agents
10/05/1999US5962448 Pyrroloazepine derivatives
10/05/1999US5962439 Cardiovascular disorder
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999CA2189534C Imidazole derivatives and processes for the preparation thereof
09/1999
09/30/1999WO1999049065A1 Antisense modulation of human mdm2 expression
09/30/1999WO1999049015A2 Cardiac-derived stem cells
09/30/1999WO1999048891A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
09/30/1999WO1999048870A1 Piperididinyl and n-amidinopiperidinyl derivatives
09/30/1999WO1999048858A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999WO1999048537A1 Use of scatter factor to enhance angiogenesis
09/30/1999WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
09/30/1999WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999WO1999048507A2 Steroidal saponins for treating alzheimer's disease
09/30/1999WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999WO1999048482A2 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
09/30/1999WO1999040945A3 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
09/30/1999WO1999040198A3 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
09/30/1999WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis
09/30/1999WO1999038518A3 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
09/30/1999WO1999035266A3 Human urotensin ii
09/30/1999WO1999029308A3 Method for combating obesity
09/30/1999WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999CA2326053A1 Use of scatter factor to enhance angiogenesis
09/30/1999CA2325943A1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999CA2325634A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
09/30/1999CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999CA2324350A1 Cardiac-derived stem cells
09/30/1999CA2324347A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999CA2322773A1 Antisense modulation of human mdm2 expression
09/30/1999CA2291066A1 Local delivery of long lasting therapeutic agents
09/29/1999EP0944720A1 Adaptor protein frs2 and related products and methods
09/29/1999EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
09/29/1999EP0944631A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/29/1999EP0944630A1 Xanthines and their therapeutic use
09/29/1999EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944621A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944619A1 Novel integrin receptor antagonists
09/29/1999EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use
09/29/1999EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
09/29/1999EP0944611A1 Dimesylate salts of neuropeptide y ligands
09/29/1999EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/29/1999EP0944599A1 Triarylethanes useful as pde iv inhibitors
09/29/1999EP0944592A1 Vitamin d3 derivatives
09/29/1999EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
09/29/1999EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
09/29/1999EP0944582A1 Ketobenzamides as calpain inhibitors
09/29/1999EP0944388A2 Inhibitors of farnesyl-protein transferase
09/29/1999EP0944309A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof
09/29/1999EP0791005B1 Smooth muscle cell proliferation inhibitors
09/29/1999EP0593520B1 Ocular compositions containing steroids and their use in treating glaucoma
09/29/1999CN1230222A PTX-sensitive G proteins, prodn. and use thereof
09/29/1999CN1230220A Therapy for 'alpha'-galactosidase deficiency
09/29/1999CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn.
09/29/1999CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof
09/29/1999CN1230178A Polydithiocarbamate-containing macromolecules and use thereof for therapeutic and diagnostic applications
09/29/1999CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect
09/29/1999CN1230173A Substituted N-arylmethylamino derivatives of cyclobutene-3,-4-diones
09/29/1999CN1230122A Medical compsns.
09/29/1999CN1230114A Novel treatment of leptine resistance
09/29/1999CN1229795A Heterocyclic compounds
09/29/1999CN1229652A Compound fish oil
09/29/1999CN1045294C Method for prepn. of indole derivatives
09/28/1999US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999US5959113 Reacting a diketone derivative with an aldehyde derivative; administering to treat atherosclerosis, psoriasis, alopecia and tumors
09/28/1999US5959107 Inhibitory activity on neuronal cell death (apoptotic cell death-type) caused by excessive apoptosis in a nervous system and they are useful for prevention or treatment of neurodegenerative disorders
09/28/1999US5959103 Naphthofluorene compounds, intermediates, compositions, and methods
09/28/1999US5958968 Cardiovascular disorders; kidney dieases
09/28/1999US5958958 1,2,4-oxa diazolino and 1,24-oxa diazolidion heterocycles as useful nitric oxide synthase inhibitors
09/28/1999US5958953 Substituted indazole derivatives
09/28/1999US5958952 Substituted phenylamindines, medicaments containing these compounds and process for producing them
09/28/1999US5958944 Treatment of circulatory diseases in coronary, cerebral, renal and peripheral arteries, as a therapeutic agent for hypertension, angina pectoris, and renal and peripheral circulation disorder, antiasthmatic agent
1 ... 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 ... 1595